KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Shares Outstanding (2016 - 2025)

Evolent Health has reported Shares Outstanding over the past 12 years, most recently at $117.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $117.6 million for Q4 2025, up 0.88% from a year ago — trailing twelve months through Dec 2025 was $117.6 million (up 0.88% YoY), and the annual figure for FY2025 was $117.6 million, up 0.88%.
  • Shares Outstanding for Q4 2025 was $117.6 million at Evolent Health, roughly flat from $117.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding for EVH hit a ceiling of $117.6 million in Q4 2025 and a floor of $86.8 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $113.9 million (2023), compared with a mean of $106.5 million.
  • Biggest five-year swings in Shares Outstanding: rose 23.38% in 2023 and later grew 0.87% in 2025.
  • Evolent Health's Shares Outstanding stood at $90.8 million in 2021, then increased by 11.84% to $101.5 million in 2022, then grew by 13.72% to $115.4 million in 2023, then rose by 1.0% to $116.6 million in 2024, then grew by 0.88% to $117.6 million in 2025.
  • The last three reported values for Shares Outstanding were $117.6 million (Q4 2025), $117.6 million (Q3 2025), and $117.5 million (Q2 2025) per Business Quant data.